GeneDx Holdings annual current ratio
2020
2021
2022
2023
2024
2025
GeneDx Holdings Current Ratio Growth & History (WGS)
GeneDx Holdings's current ratio was 2.46 for fiscal 2025.
View full GeneDx Holdings company overviewGeneDx Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.46 | −1.15 | −31.79% |
| 2024 | 2024-12-31 | 3.61 | 0.51 | +16.50% |
| 2023 | 2023-12-31 | 3.10 | 1.63 | +110.39% |
| 2022 | 2022-12-31 | 1.47 | −3.30 | −69.14% |
| 2021 | 2021-12-31 | 4.77 | 2.40 | +101.38% |
| 2020 | 2020-12-31 | 2.37 | — | — |
GeneDx Holdings quarterly current ratio
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.30 | 0.43 | +15.08% |
| Q1 2026 | 2026-03-31 | 3.09 | −0.16 | −4.90% |
| Q4 2025 | 2025-12-31 | 2.46 | −1.15 | −31.79% |
| Q3 2025 | 2025-09-30 | 2.71 | 0.31 | +12.74% |
| Q2 2025 | 2025-06-30 | 2.87 | 0.49 | +20.77% |
| Q1 2025 | 2025-03-31 | 3.25 | 0.03 | +0.81% |
| Q4 2024 | 2024-12-31 | 3.61 | 0.51 | +16.50% |
| Q3 2024 | 2024-09-30 | 2.41 | −0.11 | −4.30% |
| Q2 2024 | 2024-06-30 | 2.38 | −0.15 | −6.03% |
| Q1 2024 | 2024-03-31 | 3.22 | 0.93 | +40.78% |
| Q4 2023 | 2023-12-31 | 3.10 | 1.63 | +110.39% |
| Q3 2023 | 2023-09-30 | 2.51 | 0.62 | +33.05% |
| Q2 2023 | 2023-06-30 | 2.53 | 0.56 | +28.44% |
| Q1 2023 | 2023-03-31 | 2.29 | −1.79 | −43.90% |
| Q4 2022 | 2022-12-31 | 1.47 | −3.30 | −69.14% |
| Q3 2022 | 2022-09-30 | 1.89 | −5.63 | −74.88% |
| Q2 2022 | 2022-06-30 | 1.97 | 0.60 | +44.34% |
| Q1 2022 | 2022-03-31 | 4.08 | 2.04 | +99.78% |
| Q4 2021 | 2021-12-31 | 4.77 | 2.40 | +101.38% |
| Q3 2021 | 2021-09-30 | 7.52 | −25.52 | −77.24% |
| Q2 2021 | 2021-06-30 | 1.36 | — | — |
| Q1 2021 | 2021-03-31 | 2.04 | — | — |
| Q4 2020 | 2020-12-31 | 2.37 | — | — |
| Q3 2020 | 2020-09-30 | 33.04 | — | — |
GeneDx Holdings current ratio trends
Over the last five fiscal years, GeneDx Holdings's current ratio increased from 2.37 to 2.46, a change of 0.09. The latest reported quarter, Q2 2026, shows 3.30.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings source filings ↗